Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype
| Status: | Completed |
|---|---|
| Conditions: | Other Indications |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 12 - 17 |
| Updated: | 8/19/2018 |
| Start Date: | January 2015 |
| End Date: | December 2017 |
The aim of this research is to adapt the NF-specific adult version of the Skype 3RP for use
with adolescents, and to test its feasibility, acceptability, and preliminary effect in
improving quality of life, and in decreasing stress and psychological distress.
with adolescents, and to test its feasibility, acceptability, and preliminary effect in
improving quality of life, and in decreasing stress and psychological distress.
Inclusion Criteria:
1. Must be between the ages of 12 and 17
2. Can read and speak English at or above the 6th grade level
3. Diagnosis of neurofibromatosis type 1 or neurofibromatosis type 2 by a specialized
medical provider
Exclusion Criteria:
1. Severe active or untreated major mental illness that would interfere with study
participation, to be determined at the discretion of the study investigator (e.g.
untreated psychosis or suicidality)
2. Recent (within past 3 months) change in antidepressant medication
3. Use of formal relaxation training (including past participation in a mind-body
program), currently or in the past 6 months
4. Unable or unwilling to sign the informed consent documents
5. Unable or unwilling to participate in an intervention delivered via videoconferencing
with Skype
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
Boston, Massachusetts 02114
617-724-5200
Principal Investigator: Ana-Maria Vranceanu, PhD
Phone: 617-643-7996
Click here to add this to my saved trials
